SE

Mode of action of Kyntheum®

5 views
June 07, 2021
Kyntheum® is the first biologic that selectively targets the pro-inflammatory IL-17 receptor subunit A
1 star 2 star 3 star 4 star 5 star
Add a comment...
Post as (log out)